SVB Leerink’s Geoffrey Porges on the effectiveness of Covid-19 vaccines against variants

SVB Leerink’s Geoffrey Porges on the effectiveness of Covid-19 vaccines against variants

After a recent study was released about the B.1.351 variant’s impact on the effectiveness of Covid-19 vaccines, Geoffrey Porges, Director of Therapeutics Research and Senior Biotechnology Analyst at SVB Leerink, joins Worldwide Exchange to discuss the implications.

More News Stories

Loading...

More Political News

Loading...